Back to Search Start Over

Experiences and views of different key stakeholders on the feasibility of treating cancer-related fatigue

Authors :
Claudia Canella
Michael Mikolasek
Matthias Rostock
Matthias Guckenberger
Josef Jenewein
Esther Linka
Claudia Six
Sarah Stoll
Roger Stupp
Claudia M. Witt
Source :
BMC Cancer, Vol 20, Iss 1, Pp 1-10 (2020)
Publication Year :
2020
Publisher :
BMC, 2020.

Abstract

Abstract Background Although cancer-related fatigue (CRF) has gained increased attention in the past decade, therapy remains a challenge. Treatment programs are more likely to be effective if the needs and interests of the persons involved are well represented. This can be achieved by stakeholder engagement. In this paper, different key stakeholders’ experiences and views on the feasibility of treating CRF in the context of supportive care in hospital environments are analyzed. Method In a qualitative study with the aim of developing an integrative treatment program for CRF, a total of 22 stakeholders (6 medical oncologists, 5 nurses, 9 patients, 1 patient family member, 1 representative of the Swiss Cancer League) were interviewed either in a face-to-face (n = 12) or focus group setting (n = 2). For data analyses, the method of qualitative content analysis was used. Results The stakeholders referred to different contextual factors when talking about the feasibility of treating CRF in the context of supportive care in hospital environments. These included: assessment, reporting and information; treatability; attitude; infrastructure, time-management, costs and affordability; and integrative approach. Conclusions Key factors of a feasible treatment approach to CRF are a coherent, cost effective integrative treatment program facilitated by an interdisciplinary team of health care providers. Furthermore, the treatment approach should be patient orientated, adopting an individualized approach. The major challenges of making the integrative treatment program feasible for CRF are resources and interprofessional collaboration.

Details

Language :
English
ISSN :
14712407
Volume :
20
Issue :
1
Database :
Directory of Open Access Journals
Journal :
BMC Cancer
Publication Type :
Academic Journal
Accession number :
edsdoj.28f9b9e2afa54271a19b080f6c12303d
Document Type :
article
Full Text :
https://doi.org/10.1186/s12885-020-06858-6